Stock SUCAMPO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Sucampo Pharmaceuticals, Inc. Stock

Equities

US8649091068

Biotechnology & Medical Research

Chart Sucampo Pharmaceuticals, Inc.

Dynamic Chart

Latest news about Sucampo Pharmaceuticals, Inc.

Wall Street slips on tech sector weakness RE
Mallinckrodt : to buy Sucampo for about $840 million RE
Boeing : U.S. companies react cautiously to Trump victory RE
More news

Press releases Sucampo Pharmaceuticals, Inc.

SUCAMPO PHARMACEUTICALS, INC. Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc BU
Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference GL
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 29th Annual Piper Jaffray Healthcare Conference GL
Sucampo to Host 2017 R&D Day on November 16 in New York GL
Sucampo Reports Third Quarter 2017 Financial Results GL
More press releases

News in other languages on Sucampo Pharmaceuticals, Inc.

Apple : POINT Marchés-Wall Street finit peu changée, freinée par Apple
Apple : Les valeurs à suivre à Wall Street
Alexion Pharmaceuticals : Les valeurs à suivre à Wall Street
Sucampo Pharmaceuticals : La biotech américaine Sucampo envisage de se vendre
Sucampo Pharmaceuticals : Une nouvelle étude publiée dans PLOS ONE fait avancer la science autour du VTS 270 utilisé pour le traitement de la maladie de Niemann-Pick de type C1 (NPC-1)
More news

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-3.39% 102B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+2.61% 96.84B
ARGENX SE Stock argenx SE
-1.02% 21.48B
BIONTECH SE Stock BioNTech SE
-18.14% 20.82B
GENMAB A/S Stock Genmab A/S
-6.87% 18.6B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-40.70% 16.81B
BEIGENE, LTD. Stock BeiGene, Ltd.
-26.89% 13.78B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+1.12% 13.4B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+22.25% 11.06B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. Stock